THE INTERSECTION OF BRAIN SCIENCE & HUMAN POTENTIALPartner with us
neurofeedback.com
The newsletter
← Research & Evidence
Positive with limitationsSystematic review and random-effects meta-analysis of randomized sham-controlled trials

Transcranial alternating current stimulation as psychiatric intervention: A meta-analytic primer.

Published October 29, 2026. Across 18 sham-controlled studies involving 1,045 adults with psychiatric conditions, tACS was associated with a moderate pooled improvement in symptoms. The most consistent signals were for depression and anxiety, while results for obsessive-compulsive symptoms, inattention and post-traumatic stress came from fewer studies. The studies varied substantially, so this analysis supports further disorder-specific testing rather than showing that one tACS protocol works broadly or should be used without clinical supervision.

Razza LB, Ogircin M, Rivas-Diaz P, Wischnewski M.
Brain Stimulation · Publication date: 2026-10-29
Added to site: 2026-11-18
DOI: 10.1016/j.brs.2026.103246

Published online October 29, 2026. Added to Neurofeedback.com November 18, 2026 after comparison with fresh and retained candidates. The source publication date is separate from the site addition date.

Modalities
Transcranial alternating current stimulation, Noninvasive brain stimulation, Oscillation-targeted stimulation
Clinical focus
Psychiatric symptoms, Depression and anxiety, Sham-controlled evidence
Population
Adults with psychiatric conditions represented across 18 randomized sham-controlled studies
Sample
18 studies, 19 datasets and 1,045 participants
Intervention / method
MEDLINE/PubMed, Embase, Scopus and CENTRAL were searched through August 2026. The authors pooled standardized mean differences as Hedges' g under random-effects models and explored clinical and methodological moderators.
Comparator
Sham stimulation in the included randomized trials

Clinician summary

The pooled estimate favored active tACS over sham, SMD -0.41, 95% CI -0.60 to -0.20, with substantial heterogeneity, I2=72%. Depression analyses across 10 studies yielded SMD -0.44, 95% CI -0.76 to -0.01. Anxiety analyses across four studies yielded SMD -0.64, 95% CI -1.12 to -0.17, I2=62%. Signals in other symptom domains and frequency-specific analyses were exploratory and based on limited evidence. The checked abstract does not establish an optimal frequency, montage, dose or clinical population.

How to interpret the findings

The synthesis pooled different diagnoses, symptom measures and stimulation protocols, and the overall heterogeneity was substantial. Several symptom-domain estimates came from few studies, and the depression confidence interval was close to the null. The authoritative abstract does not report study-level risk-of-bias results, publication-bias analyses, durability, everyday functioning, adverse-event synthesis or funding. Full text was not accessible in the checked sources. The findings do not establish comparative effectiveness, an approved indication, a single optimal protocol or suitability for self-directed use.

Equipment and disclosures

The included trials used varied tACS protocols. The checked abstract does not establish superiority for a device, frequency, montage or dose, and no equipment is attributed to BrainMaster or another site sponsor.

The authors declared no known competing financial interests or personal relationships. Funding was not reported in the checked authoritative abstract, and no adverse-event synthesis was identified there. No correction, retraction or expression-of-concern notice tied to the DOI appeared in the checked PubMed record or bounded DOI and title searches on November 18, 2026; this is not assurance of absence. AI-assisted source review for Neurofeedback.com, not independent human clinical review.

Related evidence

Compare findings from the same clinical area, including mixed results.

Abstract checked · Checked 2026-11-18

Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.